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Background: Intraoperative nausea and vomiting (IONV) during spinal anaesthesia (SA) for Caesarean section (CS) is unpleasant 
and may interfere with surgery. The incidence of IONV during elective CS was studied, as well as the influence of ethnicity on this 
outcome.
Methods: A total of 258 healthy term patients undergoing SA for elective CS were recruited to this prospective observational 
study conducted at two Cape Town Level 2 hospitals. Standard practice was employed for SA for CS at the University of Cape Town: 
2 ml hyperbaric bupivacaine plus 10 μg fentanyl at the L3/4 interspace, and 15 mL/kg crystalloid coload. Spinal hypotension was 
managed with phenylephrine boluses according to a standard protocol. Nausea and/or vomiting were treated by restoration 
of blood pressure, and metoclopramide. Intraoperative complaints of nausea, and vomiting, were noted. Patients were also 
interviewed postoperatively as to any experience of intraoperative or previous history of nausea.
Results: Of the 258 patients enrolled in the audit, 112 (43.4%) were non-African and 146 (56.6%) were Black African patients. The 
overall incidence (95% CI) of nausea was 0.32 (0.27–0.38), with 20% occurring prior to and 11% after the delivery. The overall 
incidence of vomiting was 0.07 (0.05–0.11), with 3.2% occurring prior to and 3.8% after delivery. The incidence of nausea and/or 
vomiting was 0.33 (0.28 – 0.40). Black Africans experienced significantly less nausea than non-African patients (36/145 [24.8%] vs. 
47/112 [42.0%] respectively, p = 0.004). There was no significant difference in the incidence of vomiting (10/145 [6.8%] vs. 8/112 
[7.1%] respectively). The odds of experiencing intraoperative nausea for patients with any blood pressure value < 70% of baseline 
were 2.46 (95% CI 1.40–4.33).
Conclusions: Though in keeping with international standards, the clinically significant incidence of nausea and/or vomiting 
of 33% requires adjustments to the management protocol for spinal hypotension. The inclusion of ethnicity as a risk factor for 
nausea during SA for CS should be considered.
Keywords: Caesarean section, ethnicity, intraoperative, nausea and vomiting, spinal anaesthesia
Introduction
Intraoperative nausea and vomiting (IONV) causes distress to the 
patient and may interfere with the surgery. The incidence of 
IONV during spinal anaesthesia (SA) for Caesarean section (CS) is 
dependent on the anaesthesia technique used, together with 
preventative and therapeutic measures employed by the 
anaesthetist.1 There is little research on the incidence of IONV 
during SA for CS within the South African population. In a recent 
study it was shown that postoperative nausea and vomiting 
(PONV) in Black South African (African) patients undergoing 
general anaesthesia (GA) is significantly lower than in the 
remainder of the multi-ethnic South African population (non-
African).2 Clinical experience suggests that the incidence of 
nausea and vomiting during SA for CS is low in African patients. 
The primary outcome of this study was thus an assessment of the 
incidence of nausea and vomiting, and the secondary outcome 
was a comparison of the incidence of these symptoms between 
African and non-African patients during SA for CS.
Methods
A prospective observational study was conducted at Mowbray 
Maternity Hospital and New Somerset Hospital, after approval 
had been obtained from the Human Research Ethics Committee 
of the University of Cape Town. Healthy, term patients undergoing 
elective SA for CS during daylight hours were studied, during the 
period August 2014–February 2015. Exclusion criteria were three 
previous Caesarean sections, previous major abdominal surgery, 
anti-emetics administered prior to CS, preoperative or 
intraoperative systemic opioid administration, known adverse 
reaction to metoclopramide, conversion to general anaesthesia, 
pre-eclampsia or other causes of severe hypertension, and the 
use of ergometrine.
Cefazolin (1–2  g) or, if the patient was allergic to penicillin, 
clindamycin (600 mg), was given over a minimum time period of 
5 minutes, and at least 10 minutes prior to induction of SA. If 
nausea or vomiting occurred as a result of administration, it was 
noted separately. Preoperatively, systolic blood pressure (SBP) 
was measured twice with the patient in the left lateral position, 
and the mean value calculated. The target for treatment of 
hypotension was 80% of this value. The procedure included the 
standard practice for SA for CS at the University of Cape Town, i.e. 
2  ml intrathecal hyperbaric bupivacaine plus 10  μg fentanyl, 
15  ml/kg rapid crystalloid coload via a freely running infusion 
into an 18G cannula. The patient was positioned supine, with 20 
degrees left lateral tilt. Dermatomal block height was assessed 
by temperature sensitivity as assessed by ethyl chloride spray. 
Blood pressure was measured every minute for the entire 
procedure. The initial vasopressor used was phenylephrine 
50 μg, given in response to a 20% decrease in SBP. A 30% decrease 
in SBP was treated with 100  μg of phenylephrine. This was 
repeated every minute until the target SBP was achieved (within 
20% of baseline value). If the heart rate decreased to less than 55 
beats per minute in association with hypotension (SBP decreased 
by 30% from baseline), ephedrine 10  mg was administered, 
followed by atropine 0.25–0.5  mg if bradycardia persisted. 
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Ephedrine was also administered if there was a poor response to 
two consecutive doses of phenylephrine. Nausea and vomiting 
were treated with intravenous phenylephrine to restore blood 
pressure, and metoclopramide 10 mg. Oxytocin 3 IU was given 
over 60 seconds, after clamping of the cord.
The following data were collected by the attending anaesthetist: 
patient age, booking weight, gestational age, gravity, parity, and 
number of previous Caesarean sections. Also recorded was the 
lowest systolic blood pressure (SBP) during the procedure, the 
highest level of the spinal block, total fluid volume administered, 
and the total dose of phenylephrine, ephedrine, atropine and 
metoclopramide. The total blood loss was estimated by 
measurement in a graded suction bottle and inspection of 
swabs. Whether or not the uterus was exteriorised was also 
noted. Episodes of nausea and vomiting were noted, and 
whether these events occurred prior to, or after, delivery. Other 
adverse events, as well as duration of surgery, were recorded at 
completion of the case.
Interviews were conducted after the operation and consent 
requested at this time for participation in the study. This was 
done in order to exclude potential suggestion bias introduced by 
explaining the study objectives prior to surgery. The following 
direct questions were asked: ‘What race do you classify yourself?’, 
‘Have you ever experienced motion sickness or postoperative 
nausea and vomiting?’, and ‘Did you experience nausea during 
this operation?’
Statistical analysis
Sample size calculation for the primary outcome was based on a 
clinical estimate of an incidence of nausea and/or vomiting of 
25% overall, with an absolute accuracy of +/– 6%. This required 
184 patients. Sub-group analysis was planned a priori. With an 
expected proportion of African/non-African patients of 66/33%, 
and an expected incidence of nausea and/or vomiting of 15% 
amongst Black Africans and 35% in non-Africans, allowing for 
90% power and p < 0.05, 156 Black African and 78 non-African 
patients were required. In the time available for the conduction 
of the audit, 143 Black African and 112 non-African parturients 
were studied.
Individual categorical variables were summarised with frequency 
and percentage frequency distributions and illustrated using bar 
charts. Continuous variables were summarised using means and 
standard deviations or medians and interquartile ranges. 
Associations between categorical variables were summarised in 
two-way frequency tables and tested for statistical significance 
using a chi-square test. Observed p-values are quoted. P-values 
smaller than 0.05 were considered to be statistically significant. 
The joint associations between the predictor variables and the 
presence/absence of nausea/vomiting were modelled using a 
logistic regression model. The exponentiated coefficients of this 
model are estimated on adjusted odds ratios. Multinomial 
logistic regression models were used to estimate the association 
between predictor variables and the three-level categorical 
outcomes. These models are equivalent to parallel binary logistic 
models where the relative odds of each of the categories 
compared with a chosen reference category are estimated. We 
chose ‘none’ as the reference category.
Results
Two hundred and fifty-eight patients were recruited (146 Black 
South Africans and 112 multi-ethnic [non-African] parturients). 
There were no patients excluded from recruitment. One patient 
was excluded from the analysis because of erroneous recruitment 
(three previous Caesarean sections). Patient demographic data 
and baseline haemodynamic values were similar in the two 
groups (Table 1). Patient age ranged between 18 and 44 years, 
and all were American Society of Anaesthesiologists Class I or II.
Primary outcome: incidence of IONV during SA 
for CS
The overall incidence of nausea was 0.323, 95% CI 0.27–0.38, 
with 20% occurring prior to delivery of the baby and 11% after 
the delivery. The overall incidence of vomiting was 0.0698, 95% 
CI 0.05–0.11, with 3.1% prior to delivery and 3.8% after the 
delivery. The combined incidence of nausea and vomiting was 
0.333, 95% CI 0.28–0.40.
Secondary outcome: between-group 
comparison
There was a significant difference (p = 0.004) in the incidence of 
nausea between African and non-African patients (36/145 
[24.8%] vs. 47/112 [42.0%], p = 0.004; odds ratio [95% CI] = 0.47 
[0.27–0.82]). There was also a significant difference (p = 0.012) in 
the incidence of nausea and vomiting (combined) between 
African and non-African patients (38/146 [26%] vs. 48/112 [42%], 
Table 1: Patient demographic data, and relevant data pertaining to spinal anaesthesia
Notes: Statistical significance was defined as p < 0.05. NS = not significant.
Factor African Non-African p-value
Number 146 112
Age (years) 29.8 30.4 NS
Parity 2.6 2.9 NS
Number of previous Caesarean sections 1.15 1.19 NS
Weight (kg) 83.2 79.2 NS
Smoker (yes/no) 8 (5.5%) 40 (35.7%) < 0.001
History of motion sickness (yes/no) 17 (11.6%) 12 (10.7%) NS
Hypotension (% patients with SBP ≤ 70% baseline) 65 (44%) 48 (42.9%) NS
Baseline heart rate 89 87 NS
Exteriorisation of uterus 26 (17.8%) 9 (8%) 0.023
Duration of operation (minutes) 45 43 NS
Highest dermatomal level of block (mode) T3 (C5–T7) T3 (T1–T7) NS
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p = 0.012). There was no significant difference between the 
groups in respect of the incidence of vomiting: African patients 
10/145 (6.8%) and non-African patients 8/112 (7.1%).
In addition, logistic regression showed a correlation between 
hypotension (SBP <= 70% baseline) and IONV. There was no 
association between IONV and baseline heart rate, incidence of 
smoking, history of motion sickness, or exteriorisation of the uterus.
Discussion
This study showed an overall incidence of nausea of 32% during 
SA for CS. There was also a significantly lowe
r incidence in African patients than in the non-African group. The 
incidence of vomiting was low (18/258 [7%]), and not significantly 
different between the groups.
There are few studies measuring the incidence of intraoperative 
nausea and vomiting (IONV). Therefore, the incidence of IONV is 
often taken from the placebo groups of studies examining the 
effect of antiemetic preventative measures. Some review articles 
do quote the incidence of intraoperative nausea and vomiting 
(IONV) during SA for CS, but most of these have also included 
postoperative nausea and vomiting (PONV). Previous studies 
have reported varying incidences of nausea, ranging from 6.7% 
to 60%,3–5 and vomiting (12% to 58%).1,5
Many factors, anaesthetic and non-anaesthetic, contribute to the 
incidence of nausea and vomiting during Caesarean section. The 
anaesthetic risks are hypotension, the use of neuraxial and IV 
opioids, and an increase in vagal activity. The non-anaesthetic 
factors include manipulation and exteriorisation of the uterus, 
vigorous movement of the patient, and the use of uterotonic 
agents such as oxytocin.1
In a review of the incidence of nausea and vomiting during SA for 
CS, it was suggested that hypotension, baseline heart rate, spinal 
dermatomal level, a history of non-smoking, or history of motion 
sickness increases the risk of nausea and vomiting, either intra- 
or postoperatively.1 However, using logistic regression, we 
showed that heart rate, smoking and a history of motion sickness 
did not significantly increase this risk. It remains controversial 
whether exteriorisation of the uterus increases the risk of IONV.6 
We found in the present audit that although there was an 
increased incidence of vomiting in patients in whom the uterus 
was exteriorised, this was prior to delivery, and hence prior to 
exteriorisation of the uterus.
In our study, the only factor known to be associated with IONV, 
along with ethnicity, was hypotension. Many studies have shown 
a correlation between blood pressure control and IONV. A 
decrease in blood pressure of  >  30% below baseline has been 
found to increase the risk of IONV to 60%.7 The incidence of IONV 
increases in proportion to the percentage decrease from baseline 
blood pressure. Ngan Kee et al. found the incidence of IONV to be 
4%, 14%, and 40% with targets, as a percentage of baseline 
systolic blood pressure, of 100%, 90%, and 80% respectively.8 
Hypotension may be compounded by aortocaval compression 
during SA for CS, particularly if lateral tilt is not adequately 
applied.9 In the present study, the odds of experiencing nausea 
with a minimum-recorded SBP less than 70% of baseline were 
2.46 times higher than those in whom SBP was always higher 
than 70% of the baseline value. There was no difference in the 
incidence of hypotension between our two groups, and no 
difference in oxytocin use.
Some of the causes of IONV can be manipulated and controlled, 
but certain patients may be particularly susceptible. This requires 
early identification and possibly the use of pharmacological 
prophylaxis. A recent Cochrane review of interventions for 
prevention of nausea and vomiting in women undergoing 
regional anaesthesia for CS showed that many agents were 
effective in preventing IONV, keeping with the multifactorial 
pathogenesis of the condition. The best agents were 5-HT3 
antagonists, dopamine antagonists and sedatives. They also 
found that there was little evidence that combinations of 
treatments were superior to single agents.3 These medications 
are not without their risks, which may include agitation, extra-
pyramidal symptoms and arrhythmias.10 In our study, we used 
metoclopramide 10  mg as treatment of vomiting or reported 
nausea. Only 7.7% of our patients received this intervention. This 
percentage was in keeping with the incidence of intraoperative 
vomiting.
There was a significantly higher incidence of nausea in the non-
African group of patients in this study, despite the higher number 
of smokers in this group (smoking is known to be protective 
against PONV).11 It has been shown that nausea and vomiting of 
pregnancy is more common in western and Asian populations 
than in African, Eskimo and Native Americans.12 A Canadian 
study examining the racial differences in the incidence of nausea 
and vomiting of pregnancy showed that Asian and Black women 
were less likely to report these symptoms than Caucasians. This 
difference in the reporting of symptoms was attributed to 
cultural or genetic factors.13 A study investigating racial 
differences in response to chemotherapy found the African-
American population have a lower incidence of nausea and 
vomiting than Caucasian patients.14 It has been the perception 
amongst South African anaesthesiologists that Black South 
African patients have a decreased incidence of PONV after 
general anaesthesia. A prospective observational study 
performed in KwaZulu-Natal (KZN) measured the incidence of 
PONV in patients undergoing general anaesthesia, and showed a 
significant difference between Black South African (African) 
patients (27%) as opposed to multi-ethnic (non-African) patients 
(45%).2 It is postulated that the isoenzyme variation in the 
hepatic P-450 cytochrome system is a potential factor in the 
precipitation of nausea and vomiting. Patients who have a 
CYP2E1 poor-metaboliser phenotype may be at a greater risk for 
the development of PONV. This allele has not been identified in 
the KZN black population and this may explain the lower 
incidence of PONV.15 With regard to intraoperative nausea and 
vomiting during SA for CS, this mechanism does not apply. Other 
centrally mediated mechanisms may be involved.
There are certain limitations to this study. We did not use a visual 
analogue score (VAS) and thus the binary response of ‘yes’ or ‘no’ 
did not allow for the identification of different levels of nausea. 
Patient responses may also have been affected by confirmation 
bias. In addition, nausea is under-reported, and the absence of 
formally trained interpreters meant that the African patients 
might not have fully understood the meaning of the word nausea.
Nausea and vomiting remain unpleasant symptoms during SA 
for CS. We therefore regarded it as important to establish the 
incidence of these side effects in our population, using a 
standardised SA technique. The intention was to introduce 
interventions to reduce the incidence of IONV, and improve 
patient experience of the birth and bonding process. This study 
found the incidence of nausea and/or vomiting during SA for CS 
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We found in the present audit that although there was an 
increased incidence of vomiting in patients in whom the uterus 
was exteriorised, this was prior to delivery, and hence prior to 
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a correlation between blood pressure control and IONV. A 
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to be 33% in the South African population. Black South Africans 
had a significantly lower incidence of intraoperative nausea. The 
only other factor contributing to an increased incidence of IONV 
was hypotension. However, in keeping with international 
standards, the clinically significant incidence of nausea and/or 
vomiting of 33% requires adjustments to our management 
protocol for spinal hypotension. The inclusion of ethnicity as a 
risk factor for nausea during SA for CS should be considered.
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